|
References for Kidney Disease Screening
By Leslie Spry, MD
Vol. 3, Issue 6
Pp. 67-70
1. J Coresh, E Selvin, LA Stevens, et al. Prevalence of Chronic Kidney Disease in the United States. JAMA 298(17):2038-2047, 2007
2. JA Vassalotti, LA Stevens, and AS Levey. Testing for Chronic Kidney Disease: A Position Statement from the National Kidney Foundation. Am J Kidney Dis 50(2):169-180, 2007
3. RD Lindeman, J Tobin and NW Shock. Longitudinal Studies on the Rate of Decline in Renal Function with Age. J Am Geriatr Soc 33:278-285, 1985
4. DF Davies, NW Shock. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29:496-507, 1950
5. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Guideline 13: Factors associated with loss of kidney function in CKD. Am J Kidney Dis 39:S1-S266, 2002
6. AS Levey, JP Bosch, JB Lewis, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461-470, 1999
7. DW Cockcroft & MH Gault. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
8. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Guideline 1: Definition and Stages of Chronic Kidney Disease. Am J Kidney Dis 39:S1-S266, 2002
9. The National Kidney Foundation Kidney Early Evaluation Program (KEEP) available at : http://www.kidney.org/news/keep/KEEPabout.cfm Accessed on February 25, 2008.
10. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 43 (Suppl 1):S1-S290, 2004
11. Hypertension: A Companion to Brenner and Rector's The Kidney. Chapter 57 Renal Disease by G Navis, PE de Jong, and D deZeeuw. pp 524 - 531, edited by Suzanne Oparil, MD and Michael Weber, MD. Published by W. B. Saunders Company, 2000.
12. GL Bakris, M Williams, L. Dworkin, et al. Preserving Renal Function in Adults with Hypertension and Diabetes Mellitus: A Consensus Approach. Am J Kidney Dis 36(3):646-661, 2000
13. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49 (Suppl 2):S1-S180, 2007
14. Diabetes Control and Complications Trial Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on the development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA 290(16):2159-2167 (2003)
15. EJ Lewis, LG Hunsicker, RP Bain, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
16. EJ Lewis, LG Hunsicker, WR Clark, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001
17. BM Brenner, ME Cooper, D deZeeuw, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
18. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45 (Suppl 3):S1-S154, 2005
19. The DASH Diet available at the National Heart Lung and Blood Institute: http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf Accessed on February 25, 2008.
20. S Klahr, AS Levey, GJ Beck, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic kidney disease. N Engl J Med 330:877-884, 1994
21. Vanherweghem, JL. Nephropathy and herbal medicine. Am J Kidney Dis. 35:330-332 (2000).
|